InsiderTrades

Form 4 for CME CME Group

Accepted 2025-03-18 00:00:00 ET · period of report 2025-03-15 · accession 0001156375-25-000055 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
M 2025-03-18 2025-03-15 CME McCourt Timothy Francis Sr MD Gbl Head Equity, FX F - Tax $258.68 -837 7,985 -9% -$216.5K
M 2025-03-18 2025-03-15 CME McCourt Timothy Francis Sr MD Gbl Head Equity, FX A - Grant $258.68 +1,451 7,592 +24% +$375.3K

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock Class A 2025-03-15 F D 96 $258.68 7,889 D — — (F4) Mr. McCourt surrendered shares to the Company in order to fulfill tax withholding obligations upon the vesting of restricted stock on 3/15/2025.
2 Common Common Stock Class A 2025-03-15 F D 162 $258.68 7,430 D — — (F2) Mr. McCourt surrendered shares to the Company in order to fulfill tax withholding obligations in connection with the receipt of the performance share award.
3 Common Common Stock Class A 2025-03-15 A A 1,134 $258.68 8,564 D — — (F3) For the PSAs granted in March 2022: Represents shares earned from a March 2022 performance share award based on the company's achievement of total shareholder return relative to the S&P 500 measured over 2022-2024.
4 Common Common Stock Class A 2025-03-15 F D 579 $258.68 7,985 D — — (F2) Mr. McCourt surrendered shares to the Company in order to fulfill tax withholding obligations in connection with the receipt of the performance share award.
5 Common Common Stock Class A 2025-03-15 A A 317 $258.68 7,592 D — — (F1) For the PSAs granted in September 2021: Represents shares earned from a 2021 performance share award based on the company's achievement of total shareholder return relative to the S&P 500 measured over 2022-2024.